![Page 1: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/1.jpg)
Developments in Preclinical Tools
to Predict IVIVC
©2016 Absorption Systems
PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL DEVICES
Karen Doucette
January 26, 2016
![Page 2: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/2.jpg)
Absorption 101
Release Rate Permeability Solubility
Dissolution Absorption
Formulated
Drug
Solubilized
Drug
Factors
Drug in
Enterocyte
Solubility
Determinants
![Page 3: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/3.jpg)
Limits to Oral Drug Absorption
Aqueous Solubility
Intestinal Permeability
Gastric Dissolution Gastric emptying
Luminal contents
pH range
GI transit time
![Page 4: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/4.jpg)
Absorptive Flux
= Cint • Pwall
Absorptive Flux (J)
Amidon.G et. al. A Theoretical Basis for a Biopharmaceutics Drug Classification:
The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability, Pharm Res (12) No. 3, 1995.
Pwall = effective or BCS
permeability
Cint = concentration in
lumen
![Page 5: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/5.jpg)
IDAS1 Applications
Fed vs fasted
Product development
Comparison of formulations to be manufactured/tested
in vivo
Equivalence
![Page 6: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/6.jpg)
BCS Classification
Class II
Class I
Class IV
Class III
High Solubility Low Perm
eab
ilit
y L
ow
H
igh
![Page 7: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/7.jpg)
Dissolution-Permeability Relationship: Class I
![Page 8: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/8.jpg)
Dissolution-Permeability Relationship: Class II
![Page 9: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/9.jpg)
Dissolution-Permeability Relationship: Class III
![Page 10: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/10.jpg)
Dissolution-Permeability Relationship: Class IV
![Page 11: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/11.jpg)
IDAS2 Applications
Fed vs fasted
Product development
Comparison of formulations to be manufactured/tested
in vivo
Equivalence
Screening solid dosage forms for in vivo testing
Comparison with innovator product
![Page 12: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/12.jpg)
Dissolution-Permeability Data
![Page 13: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/13.jpg)
Benefits of Caco-2
Caco-2 cells express the most common intestinal efflux and uptake transporters
DM β-actin P-gp BCRP MRP2 1B1 1B3 2B1 MRP1 DM
Intestinal Enterocytes C2BBe1 Monolayer
![Page 14: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/14.jpg)
Correlation: Caco-2 Papp vs. Human Fabs
![Page 15: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/15.jpg)
Extension to BCS III
High solubility, low
permeability
Very rapid dissolution (>
85% in 15 min)
Qualitatively the same and
quantitatively very similar
(SUPAC level 1 or 2)
![Page 16: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/16.jpg)
Rat In Situ Intestinal Perfusion
Syringe
Pump
![Page 17: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/17.jpg)
Active Uptake
Peff
(x 10-4 cm/s) Fabs
Rat Human
Antipyrine 1.3 100%
Minoxidil 0.35 100%
Pregabalin 0.27 90%
Metoprolol 0.15 90%
Atenolol -0.44 50%
![Page 18: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/18.jpg)
Excised Tissue Permeability
![Page 19: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/19.jpg)
Formulation Evaluation
Test Compound Atenolol Antipyrine
Control 2.82 9.05 23.57
EGTA 4.78 15.15 28.07
C10 4.65 17.59 25.09
Known tight junction modifiers EGTA and C10
resulted in an increase in test compound and
atenolol paracellular permeability.
EGTA and C10 did not affect antipyrine as it exhibits
transcellular permeation
![Page 20: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/20.jpg)
Variability – Representative Tools
Excised Tissue Perfusion Caco-2
Mean STD CV Mean STD CV Mean STD CV
Atenolol 1.65E-6 1.04E-6
57%
7.33E-6 5.22E-6
49%
2.25E-7 1.39E-7
31% Antipyrine 5.59E-6 3.96E-6 9.54E-6 4.47E-6 6.25E-5 1.54E-5
Metoprolol 3.04E-6 1.11E-6 1.50E-6 7.20E-6 2.79E-5 2.51E-6
![Page 21: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/21.jpg)
Components of Bioavailability
Bioavailability
Absorption
fabs
First Pass
fG • fH
Permeability Solubility
Metabolism
Hepatic Intestinal
![Page 22: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/22.jpg)
Issue-Based ADME: Ported Models
Determine the barriers to bioavailability using surgically modified
rats or dogs
Portal Vein Systemic
Oral
Duodenum
Colon
Bile Duct
Duodenum
Bile Duct
Portal Vein
Colon
Chemical Stability
Protein
Binding Metabolism
— CYPs
— UGTs
Biliary Excretion
— P-gp
— MRP2
— BCRP
Solubility
Dissolution
Permeability
Metabolism
Transporters
![Page 23: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/23.jpg)
Barriers to Bioavailability - Rat
Route of Administration Sampling Site Result
IV JVC
IPV JVC fH
PO or ID JVC fabs · fG · fH
IPV vs PO JVC fabs · fG
![Page 24: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/24.jpg)
Barriers to Bioavailability - Dog
Route of Administration Sampling Site Result
ID vs IV CV fabs · fG · fH
ID vs IPV CV fabs · fG
IPV vs IV CV fH (Method 1)
ID PV vs CV fH (Method 2)
Dose-normalized AUCs for different dosing and
sampling regimens
![Page 25: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/25.jpg)
Barriers to Bioavailability - Dog
Method 1:
IPV dose + CV sampling
vs. IV dose + CV sampling
Fh
![Page 26: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/26.jpg)
Barriers to Bioavailability - Dog
Method 1:
IPV dose vs IV dose
with CV sampling
Method 2:
ID dose with CV sampling vs.
PV sampling
![Page 27: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/27.jpg)
Multi-Platform Approach
Caco-2 Cell Monolayers
Excised Tissue Permeability
Intestinal Perfusion
Ported Animal Models
![Page 28: Developments in Preclinical Tools to Predict IVIVC...Developments in Preclinical Tools to Predict IVIVC ©2016 Absorption Systems PRECLINICAL TESTING FOR DRUGS, BIOLOGICS AND MEDICAL](https://reader034.vdocuments.us/reader034/viewer/2022050510/5f9a823acc26bc5a1167c1c9/html5/thumbnails/28.jpg)
Building Weight of Evidence
Product Performance Testing
IV-IVC
In Vivo
Ex Vivo In Vitro
28